GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Afentra PLC (LSE:AET) » Definitions » EPS (Diluted)

Afentra (LSE:AET) EPS (Diluted) : £-0.04 (TTM As of Jun. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Afentra EPS (Diluted)?

Afentra's Earnings per Share (Diluted) for the six months ended in Jun. 2023 was £-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.04.

Afentra's EPS (Basic) for the six months ended in Jun. 2023 was £-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.04.

Afentra's EPS without NRI for the six months ended in Jun. 2023 was £-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.04.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Afentra EPS (Diluted) Historical Data

The historical data trend for Afentra's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Afentra EPS (Diluted) Chart

Afentra Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.01 -0.01 -0.02 -0.03

Afentra Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.01 -0.02 -0.01

Competitive Comparison of Afentra's EPS (Diluted)

For the Oil & Gas E&P subindustry, Afentra's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Afentra's PE Ratio Distribution in the Oil & Gas Industry

For the Oil & Gas industry and Energy sector, Afentra's PE Ratio distribution charts can be found below:

* The bar in red indicates where Afentra's PE Ratio falls into.



Afentra EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Afentra's Diluted EPS for the fiscal year that ended in Dec. 2022 is calculated as

Diluted EPS (A: Dec. 2022 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-7.46-0)/220.054
=-0.03

Afentra's Diluted EPS for the quarter that ended in Jun. 2023 is calculated as

Diluted EPS (Q: Jun. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-3.067-0)/215.167
=-0.01

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Afentra  (LSE:AET) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Afentra EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Afentra's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Afentra (LSE:AET) Business Description

Traded in Other Exchanges
Address
High Holborn House, 52-54 High Holborn, London, GBR, WC1V 6RL
Afentra PLC is an upstream oil and gas company operating in the United Kingdom. The company is engaged in the exploration and production of oil and gas with a primary focus on emerging markets including, Africa and the Middle East, and has a high-potential exploration asset the Odewayne Block covers a very large area onshore southwestern Somaliland, located adjacent to the border with Ethiopia.

Afentra (LSE:AET) Headlines

From GuruFocus

Here's a Stock-Market Tool That Isn't Used Much

By John Dorfman John Dorfman 07-20-2016

Huge Long Term Upside Still Available In Aetna Inc.

By Quantified Alpha Quantified Alpha 05-14-2015

Aetna, Cisco Top Greenblatt Magic Formula Screener

By Sheila Dang Sheila Dang 06-15-2015

3 Strong ROC Stocks to Buy. Part 2

By Tiziano Frateschi Tiziano Frateschi 01-14-2015

Is This the Time to Buy Insurance Companies?

By Mark Yu Mark Yu 02-16-2016

Analysts Take Action on Health Care Stocks

By Alberto Abaterusso Alberto Abaterusso 01-23-2018

David Dreman's Top 5 Health Care Buys for the 2nd Quarter

By Sydnee Gatewood Sydnee Gatewood 08-25-2017